by Rosalyn Carson-DeWitt, MD
Parkinson's disease (PD) is a movement disorder. The symptoms get worse over time and can include:
PD is caused by a loss of certain nerve cells in the brain. The loss of these cells causes a decrease in the amount of a brain chemical called dopamine. Low dopamine levels cause PD symptoms.
The brain cells may be lost because of genetic defects, the environment, or some combination of the two. A small amount of people with PD have an early-onset form. This type is caused by an inherited gene defect.
Secondary PD has similar symptoms but is caused by several factors such as:
Factors that increase the chance of PD include:
Symptoms of PD begin mildly. They will worsen over time.
Symptoms include:
The doctor will ask about your symptoms and medical history, and perform a physical exam. There are no tests to definitively diagnose PD. The doctor will ask many questions. This will help to rule out other causes of your symptoms.
Tests to rule out other conditions may include:
Currently, there are no treatments to cure PD. There are also no proven treatments to slow or stop its progression. Some medications may help to improve symptoms. Over time, the side effects of the medication may become troublesome. The medications may also lose their effectiveness.
Examples of medicines include:
Depression or hallucinations may also occur with PD and its treatment. Medicines may be prescribed to attempt to treat these conditions. The drugs may include:
Hip fractures are common in those with PD. Bisphosphonates are medications that may help reduce this risk.
Constipation, drooling, and lightheadedness when standing are common and may improve with medications or other treatments.
Different brain operations are available, and many more are being researched including:
Therapy can improve muscle tone, strength, and balance. It will include exercises and stretches.
Consider joining a support group with other people with PD. It will help to learn how others are learning to live with the challenges of PD.
If you are diagnosed with PD, follow your doctor's instructions.
There are no guidelines for preventing PD.
National Parkinson Foundation
http://www.parkinson.org
Parkinson's Disease Foundation
http://www.pdf.org
Health Canada
http://www.hc-sc.gc.ca
Parkinson Society Canada
http://www.parkinson.ca
Alvarez MVG, Evidente VGH. Understanding drug induced parkinsonism: separating pearls from oysters. Neurology. 2008;70:e32-34.
Parkinson disease. American Association of Neurological Surgeons website. Available at: http://www.aans.org/Patient%20Information/Conditions%20and%20Treatments/Parkinsons%20Disease.aspx. Updated 2005. Accessed August 22, 2012.
Frank S. Parkinson's disease. In: Gilman S, ed. MedLink Neurology. San Diego, CA: MedLink Corporation. Available at: http://www.medlink.com. Accessed November 8, 2009.
Goetz CG. Textbook of Clinical Neurology. Philadelphia, PA: WB Saunders Company; 1999.
Liu R, Gao X, et al. Meta-analysis of the relationship between Parkinson disease and melanoma. Neurology. 2011;76:2002-2009.
Managing your PD. Parkinson’s Disease Foundation website. Available at: http://www.pdf.org/en/managing_pd. Accessed August 22, 2012.
Nielsen NM, Rostgaard K, et al. Poliomyelitis and Parkinson disease. JAMA. 2002;287:1650-1651.
Obeso JA, et al. Missing pieces in the Parkinson’s disease puzzle. Nature Medicine. 2010;16(6):653-661.
Parkinson's disease. EBSCO DynaMed website. Available at: https://dynamed.ebscohost.com/about/about-us. Updated June 6, 2012. Accessed August 22, 2012.
Parkinson Disease. National Institute of Neurological Disorders and Stroke website. Available at: http://www.ninds.nih.gov/disorders/parkinsons_disease/parkinsons_disease.htm. Accessed August 22, 2012.
Perlmutter JS, Eidelberg D. To scan or not to scan: DaT is the question. Neurology. 2012;78:688-689.
Ristić AJ, Vojvodić N, et al. The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy. Epilepsia. 2006:47(12):2183-2185.
Rowland LP, Merritt HH. Merritt's Neurology. 11th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.
Samii A, et al. Parkinson's disease. Lancet. 2004;363:1783-1793.
Samuels MA, Feske SK. Office Practice of Neurology. Philadelphia, PA: Churchill Livingstone; 2003.
Schenkman N, et al. Exercise for people in early- or mid-stage Parkinson disease: a 16-month randomized controlled trial. Phys Ther. 2012.
Siderowf A, et al. Update on Parkinson's disease. Ann Intern Med. 2003;138:651-658.
Wider C, Wszolek CK. Movement disorders: insights into mechanisms and hopes for treatments. Lancet Neurology. 2009;8(1):8-10.
1/4/2011 DynaMed's Systematic Literature Surveillance: US Food and Drug Administration. FDA announces voluntary withdrawal of Pergolide products [press release]. March 29, 2007. United States Food and Drug Administration website. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108877.htm.
1/4/2011 DynaMed Systematic Literature Surveillance https://dynamed.ebscohost.com/about/about-us: Spinks A, Wasiak J, Bernath V, Villaneuva E. Scopolamine (hyoscine) for preventing and treating motion sickness. Cochrane Database Syst Rev. 2009;(4):CD002851.
Last reviewed September 2012 by Rimas Lukas, MD
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.